Vector VestAdvertisement
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

ANX i like this!! anyone see that gap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
semipro11 Member Profile
 
Followed By 323
Posts 25,529
Boards Moderated 2
Alias Born 04/04/08
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/27/2015 4:35:55 PM
Mast Therapeutics Announces Management Change "PR Newswire (US)" - 1/24/2015 7:30:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/21/2015 2:55:44 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2015 8:31:25 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/7/2015 12:51:16 PM
Mast Therapeutics To Present At 2015 Biotech Showcase Conference On January 12th "PR Newswire (US)" - 1/7/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/6/2015 8:14:31 AM
Mast Therapeutics Provides Update On Epic Study Enrollment And 2015 Milestones "PR Newswire (US)" - 1/5/2015 5:17:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 6:56:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 6:53:16 PM
Mast Therapeutics To Host Corporate Conference Call "PR Newswire (US)" - 12/30/2014 8:00:00 AM
Mast Announces Plans For Development Of Vepoloxamer (MST-188) In Heart Failure "PR Newswire (US)" - 12/9/2014 8:00:00 AM
Mast Therapeutics To Present At The 26th Annual Piper Jaffray Healthcare Conference On December 3rd "PR Newswire (US)" - 11/26/2014 8:00:00 AM
New Data From Nonclinical Heart Failure Study To Be Presented At American Heart Association Conference "PR Newswire (US)" - 11/19/2014 8:00:00 AM
Mast Therapeutics To Present MST-188 Data At 2014 American Society Of Hematology Conference "PR Newswire (US)" - 11/17/2014 8:00:00 AM
Mast Therapeutics Announces Closing Of Underwritten Public Offering "PR Newswire (US)" - 11/13/2014 8:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/7/2014 1:57:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2014 6:02:54 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/7/2014 6:02:54 AM
Mast Therapeutics Announces Pricing Of Underwritten Public Offering "PR Newswire (US)" - 11/6/2014 9:20:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/5/2014 5:15:15 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 10/31/2014 4:16:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/31/2014 8:26:28 AM
Mast Therapeutics Reports Third Quarter 2014 Financial Results "PR Newswire (US)" - 10/31/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2014 7:46:19 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist